| Does therapy-related AML have a poor prognosis, independent of the cytogenetic/molecular determinants? | |
| | |
MedLine Citation:
|
PMID: 22127315 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Do patients with therapy-related acute myeloid leukemia (t-AML) have a poor prognosis independent of other predictive variables such as cytogenetics or molecular determinants? Limited data exist to answer this question in part because t-AML is often considered together with AML following myelodysplastic syndromes (MDS) in the category of secondary AML. This discussion provides some insight, based primarily on two published retrospective reviews of the German cooperative groups, into the question of whether t-AML is an independent adverse variable. |
| | |
Authors:
|
Eric J Feldman |
Related Documents
:
|
18469445 - Pancreatic cysts causing biliary obstruction in von hippel lindau syndrome. 17454215 - Acute pancreatitis and cholecystitis associated with postpartum hellp syndrome: a case ... 7215725 - Gut hormone responses in the irritable bowel syndrome. 8235665 - Osteonecrosis: current perspectives on pathogenesis and treatment. 10622455 - Early onset cerebellar ataxia with retained tendon reflexes: foot deformity in a first ... 19119135 - A rare cause of syndromic hypotrichosis: nicolaides-baraitser syndrome. |
Publication Detail:
|
Type: Journal Article Date: 2011-11-02 |
Journal Detail:
|
Title: Best practice & research. Clinical haematology Volume: 24 ISSN: 1532-1924 ISO Abbreviation: Best Pract Res Clin Haematol Publication Date: 2011 Dec |
Date Detail:
|
Created Date: 2011-11-30 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101120659 Medline TA: Best Pract Res Clin Haematol Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 523-6 Citation Subset: IM |
Copyright Information:
|
Copyright © 2011 Elsevier Ltd. All rights reserved. |
Affiliation:
|
Weill Cornell Medical College, 525 East 68th Street, NY 10021, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: What is the optimal induction strategy for older patients?
Next Document: Is a nadir bone marrow required and, if so, what to do with residual disease?